Cystic fibrosis-related deaths in infancy and the effect of newborn screening

Pediatric Pulmonology
I J DoullM C Goodchild

Abstract

Although newborn screening for cystic fibrosis (CF) is widely advocated, hard evidence in its favor is difficult to obtain, partly because of a dramatically improved life expectancy. Between 1985--1989 infants, born in Wales and the West Midlands were randomized to newborn CF screening by heel-prick immunoreactive trypsin (IRT) measurement or diagnosis by clinical presentation. Eligible children with CF who died in the first 5 years of life were identified from the local pediatricians and from the National UK CF Survey. In all, 230,076 infants were randomized to be screened, while 234,510 were unscreened. One hundred seventy-six CF children were identified, of whom 7 died in the first 5 years of life, 3 having presented with meconium ileus. Median age of diagnosis in the screened group was 8 weeks. On an intention to treat analysis, all 4 nonmeconium ileus-related deaths occurred in the unscreened group (Fisher's exact test, P < 0.05). However, the clinical presentation of 2 of these infants led to them being diagnosed prior to 8 weeks, i.e., earlier than would have been likely by screening. In conclusion, newborn screening has the potential to decrease infant CF deaths, but if it is to be successful, identification and treatme...Continue Reading

Citations

Jul 10, 2007·Journal of Inherited Metabolic Disease·K O McKay
Dec 6, 2003·The Journal of Pediatrics·Michael H Farrell, Philip M Farrell
Nov 25, 2003·Paediatric Respiratory Reviews·Carlo Castellani
Nov 25, 2003·Paediatric Respiratory Reviews·Kevin W Southern, James M Littlewood
Oct 18, 2005·Genetic Testing·Erin LagoePeter T Rowley
Jun 14, 2003·Current Opinion in Pediatrics·Jeffrey S WagenerFrank J Accurso
Sep 4, 2010·Current Opinion in Pulmonary Medicine·Carlo Castellani, John Massie
Jun 30, 2011·Lung India : Official Organ of Indian Chest Society·Tasaduq Ahmad MirJavid Ahmed
Sep 15, 2015·Expert Review of Respiratory Medicine·Tanja Gonska, Felix Ratjen
Nov 26, 2008·Paediatric Respiratory Reviews·Mark Rosenthal
Oct 19, 2010·Acta Paediatrica·Isabelle de MonestrolLena Hjelte
Oct 6, 2005·The Journal of Pediatrics·Jeannette E Dankert-Roelse, Marieke E Mérelle
Oct 6, 2005·The Journal of Pediatrics·Preston W Campbell, Terry B White
May 27, 2015·The Journal of Pediatrics·Hara Levy, Philip M Farrell
Jul 8, 2010·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Isabelle Sermet-GaudelusUNKNOWN European Cystic Finrosis Society (ECFS), Neonatal Screening Working Group
Jul 28, 2006·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Kevin W SouthernUNKNOWN ECFS CF Neonatal Screening Working Group
Feb 12, 2008·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Philip M Farrell
Oct 24, 2006·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Janette MoranKeith G Brownlee
Feb 28, 2009·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Carlo CastellaniStuart Elborn
Oct 7, 2004·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Gerd DöringUNKNOWN Consensus Study Group
Feb 9, 2005·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Marie des GeorgesMireille Claustres
May 27, 2008·Pediatric Pulmonology·Melanie Sue CollinsMichelle M Cloutier
Jan 23, 2009·The Cochrane Database of Systematic Reviews·Kevin W SouthernA D Nagelkerke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.